Overview
- 7 public-safe observations are available for this inspection.
- 7 structured CFR citations are represented.
- 2 investigators are tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
19 Mar 2015
21 CFR 211.113(b)
Procedures for sterile drug products
Cited by Alan P Kurtzberg, Daniel J Roberts
19 Mar 2015
21 CFR 211.122(d)
Label storage access limited to authorized personnel
Cited by Alan P Kurtzberg, Daniel J Roberts
19 Mar 2015
21 CFR 211.142(b)
Storage under appropriate conditions
Cited by Alan P Kurtzberg, Daniel J Roberts
19 Mar 2015
21 CFR 211.192
Written record of investigation incomplete
Cited by Alan P Kurtzberg, Daniel J Roberts
19 Mar 2015
21 CFR 211.204
Returned drug products identified and held
Cited by Alan P Kurtzberg, Daniel J Roberts
Inspected site
KPK.C. Pharmaceuticals, IncPomona, United States
Inspection team
DJDaniel J Roberts
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.113(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.122(d) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.142(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.204 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.68(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.68(b) | Cited across public-safe Form 483 observations | 1x |
Full 483 report
Get the verbatim text of all 7 observations
Every observation in full, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere